StaniPharm Co-Authors Study on Vaping Technologies for Medical THC Delivery
StaniPharm Co-Authors Study on Vaping Technologies for Medical THC Delivery Read the publication A new study published in the Journal of Drug Delivery Science and Technology evaluates two vaping technologies for delivering medical THC by inhalation, a CE-marked medical device (BIKY Breathe) and a commercial vape pen, with StaniPharm co-authoring the work alongside Mines Saint-Étienne […]
StaniPharm has manufactured clinical batches of Muco-Excipient for Lovaltech’s intranasal vaccine, as the MUCOBOOST clinical trial gets underway
On 14 March 2025, Lovaltech announced the launch of MUCOBOOST, the First-in-Human clinical trial for its intranasal vaccine candidate
StaniPharm and LiteVax bring a novel vaccine adjuvant from bench to First-in-Human trial in the INDIGO consortium
Developed by Dutch biotech LiteVax and manufactured by StaniPharm, the adjuvant is at the heart of the EU-India INDIGO consortium’s effort to build more accessible, dose-sparing influenza vaccines.
A look back at some of 2021’s key highlights at StaniPharm
Manufacturing of clinical GMP batches of a new vaccine adjuvant, development and manufacturing of innovative cannabis-based medicines, medical cannabis in France …
Vaxinano partners with StaniPharm for development and production of its vaccine delivery system
“Scaling up this kind of vaccine delivery system is a crucial step and requires a strong partner” says Dr. Didier Betbeder, CEO of Vaxinano.
Cybernano and StaniPharm join forces to develop tomorrow’s health products
The complementary nature of their expertise and technologies will provide complete support for start-ups and SMEs from development through clinical trials.